Table 1 Baseline characteristics of included studies
Author, Year | Name of cohort | Country | Sample size | Duration of follow-up (year) | Age, year | Female, % | Types of exposure | Types of outcomes |
|---|---|---|---|---|---|---|---|---|
MICHAUD [31] | The Health Professionals Follow-up Study | USA | 47,909 | 10 | NR | 0 | Fruit juice | Bladder cancer |
Ellison [32] | NCS | Canada | 3400 | NR | 50 to 84 years | 0 | SSB | Prostate cancer |
Schernhammer [16] | NHS | USA | 88,794 | 20 | 46.30 | 100 | SSB; ASB | Pancreatic cancer |
Schernhammer [16] | HPFS | USA | 49,364 | 20 | 47.73 | 0 | SSB; ASB | Pancreatic cancer |
Larsson [33] | SMC | USA | 35,273 | 7.2 | 62.08 | 100 | SSB | Pancreatic cancer |
Larsson [33] | COSM | USA | 42,524 | 7.2 | 59.7 | 0 | SSB | Pancreatic cancer |
Lee [34] | NHS | USA | 68,738 | 20 | 52.98 | 100 | SSB | Kidney cancer |
Lee [34] | HPFS | USA | 47,918 | 14 | 54.43 | 0 | SSB | Kidney cancer |
Nöthlings [35] | Multiethnic Cohort Study | USA | 162,150 | 8 | 59.76 | 55.1 | Fruit juice | Pancreatic cancer |
Bao [36] | NIH-AARP Diet and Health Study | USA | 487,922 | 7.2 | 62.17 | 0 | SSB; ASB; Total soft drinks | Pancreatic cancer |
Ren [37] | NIH-AARP Diet and Health Study | USA | 481,563 | NR | 50–71 | 40.53 | SSB | Oral; pharynx; larynx; esophagus; gastric cancer |
Mueller [38] | SCHS: | Singapore | 60,524 | 14 | 56.33 | 55.9 | SSB; Fruit juice | Pancreatic cancer |
Fung [39] | NHS + HPFS | USA | 132,392 | 26 | NR | 100 | SSB | Colorectal cancer |
Zhang [40] | Pooled analysis | China | 731,441 | 6–20 | 25–90 | NR | SSB | Colon cancer |
Ros [41] | EPIC | Europe | 233,236 | 9.3 | 25–70 | NR | Total soft drink | Urinary tract cancer |
Allen [42] | Million Women Study | UK | 779,369 | 5.2 | 59.4 | 100 | SSB; Fruit juice | Kidney cancer |
Friberg [43] | SMC | Sweden | 61,226 | 18.4 | 53.83 | NR | Total soft drink | Endometrial cancer |
Drake [44] | MDC | Sweden | 28,098 | 14.9 | 59.00 | 60.63 | SSB; Fruit juice | Prostate cancer |
Schernhammer, 2012 [18] | NHS | USA | 77,218 | 22 | 53.70 | 100 | SSB; ASB | Non-Hodgkin lymphoma; Myeloma; Leukemia |
Schernhammer, 2012 [18] | HPFS | USA | 47,810 | 22 | 50.60 | 0 | SSB; ASB | Non-Hodgkin lymphoma; Myeloma; Leukemia |
Inoue-Choi 2013 [45] | IWHS | USA | 41,836 | 4 | 61.62 | 100 | SSB; 100% Fruit juice | Endometrial Cancer |
Stepien [46] | the European Prospective Investigation into Cancer and Nutrition cohort | Europe | 477,206 | 11.4 | 51.21 | 70.2 | Total soft drinks | Liver cancer |
Odegaard [47] | SCHS | China | 52,584 | 16.3 | 55.77 | 56.02 | SSB; 100% Fruit juice | Overall cancer |
McCullough [48] | CPS-II Nutrition Cohort | USA | 100,442 | 10 | 69.20 | 56.84 | SSB; ASB | Non-Hodgkin lymphoma |
Wu [49] | HPFS | USA | 41,530 | 24–26 | 53.31 | 0 | Fruit juice | Basal cell carcinoma; squamous cell carcinoma |
Wu [49] | NHS | USA | 63,759 | 50.09 | 100 | Fruit juice | Basal cell carcinoma; squamous cell carcinoma | |
Wu [50] | HPFS | USA | 105,432 | NR | NR | NR | Fruit juice | Melanoma |
Hodge [51] | MCCS | Australia | 35,393 | 11.6 | 54.69 | 60.38 | SSB; ASB | Overall; Prostate; Ovary; Kidney; Colorectal; Breast; endometrial; Gastric cancer |
Zamora-Ros [52] | EPIC | Europe | 519,978 | 14 | 35–70 | 70 | Fruit juice | Thyroid cancer |
Miles [53] | PLCO | Canada | 38,343 | 9 | 65.6 | 0 | SSB; ASB; Fruit juice | Prostate Cancer |
Makarem [54] | FOS | USA | 3418 | NR | 54.34 | 52.98 | SSB; Fruit juice | Breast; Prostate; Colorectal cancer |
Bassett et al. [55] | MCCS | Australia/New Zealand/other, United Kingdom; Italy; Greece | 35,109 | 19 | 54.7 | 60.69 | SSB | Prostate; lymphoma; gastric; Melanoma; breast; bladder; Brain cancers; Leukemia |
Luo et al. [56] | NHS | USA | 87943 | 32 | 58.65 | 100 | SSB | Liver cancer |
Luo et al. [56] | HPFS | USA | 49665 | 0 | SSB | Liver cancer | ||
Pacheco et al. [57] | CTS | USA | 99798 | 20 | 51.58 | 100 | SSB | Colorectal Cancer |
Romanos-Nanclares [58] | SUN | Spain | 10713 | 10 | 34.76 | 100 | SSB | Breast cancer |
Chazelas,2019 [13] | NutriNet-Santé prospective cohort | French | 101257 | 5.1 | 42.2 | 78.7 | SSB; ASB; Fruit juice | Overall; Breast; Colorectal; Prostate cancer |
Debras [59] | NutriNet-Santé cohort | France | 101,279 | 5.9 | 40.8 | 78.73 | SSB | Breast cancer |
Hokkaido | Japan | 3158 | 14.3 | 58.00 | 51.74 | SSB | Overall, colorectal cancer | |
Heath [60] | EPIC | Europe | 389,220 | 15 | 68.00 | 51.80 | Total soft drink; SSB; ASB; Fruit juice | Kidney cancer |
Arthur [61] | CSDLH | Canada | 73,909 | 12 | NR | 53.60 | SSB; Fruit juice | Breast, Endometrial, Ovarian, Colorectal cancer |
Hur [62] | NHSII | USA | 95,464 | 24 | 41.55 | 100 | SSB; ASB, Fruit juice | Colorectal cancer |
Chen [63] | HMAC | China | 491,929 | 25 | 39.9 | 52.14 | SSB | Pancreatic cancer |
Romanos-Nanclares [64] | NHSII NHS | USA | 90,085 82,713 | 26 36 | 36.5 46.2 | 100 | SSB; ASB; | Breast cancer |
Yuan [65] | HPFS NHS | USA | 51,529 121,700 | 28 30 | 40–75 30–55 | 0 100 | SSB | Overall, Colon, Rectum cancer |
Ringel [66] | NR | USA | 93,676 | 13.5 | 50–79 | 100 | ASB | Urinary tract cancer |